» Articles » PMID: 18272392

Extracellular Tau Promotes Intracellular Calcium Increase Through M1 and M3 Muscarinic Receptors in Neuronal Cells

Overview
Date 2008 Feb 15
PMID 18272392
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular tau promotes an increase in the level of intracellular calcium in cultured neuronal cells. We have found that such increase is impaired in the presence of antagonists of muscarinic receptors. In order to identify the nature of those receptors, we have tested the effect of different specific muscarinic receptor antagonists on tau promoted calcium increase. Our results indicate that the increase does not take place in the presence of antagonists of muscarinic (mainly M1 and M3) receptors. A similar increase in intracellular calcium was found in non-neuronal cells transfected with cDNA of M1 and M3 muscarinic receptors when tau was added. These results suggest that observed effect of tau protein on neuronal (neuroblastoma and primary cultures of hippocampal and cortical neurons) cells is through M1 and M3 muscarinic receptors. Therefore blocking M1 and for M3 receptors, by using specific receptor antagonists, can prevent that tau toxic effect that could take place in tauopathies.

Citing Articles

Non-linear association of liver enzymes with cognitive performance in the elderly: A cross-sectional study.

Zhang Y, Jia S, Yang B, Miao J, Su C, Cui Z PLoS One. 2024; 19(7):e0306839.

PMID: 39042647 PMC: 11265699. DOI: 10.1371/journal.pone.0306839.


Cellular and pathological functions of tau.

Bravo C, Naguib S, Gan L Nat Rev Mol Cell Biol. 2024; 25(11):845-864.

PMID: 39014245 DOI: 10.1038/s41580-024-00753-9.


Endogenous tau released from human cultures by neuronal activity is phosphorylated at multiple sites.

Sindi G, Ismael S, Uddin R, Slepchenko K, Colvin R, Lee D bioRxiv. 2024; .

PMID: 38854111 PMC: 11160771. DOI: 10.1101/2024.06.02.597022.


Sleep-wake body temperature regulates tau secretion in mice and correlates with CSF and plasma tau in humans.

Canet G, Da Gama Monteiro F, Rocaboy E, Diego-Diaz S, Khelaifia B, Kim J Res Sq. 2024; .

PMID: 38798432 PMC: 11118695. DOI: 10.21203/rs.3.rs-4384494/v1.


Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease.

Penny L, Lofthouse R, Arastoo M, Porter A, Palliyil S, Harrington C Transl Neurodegener. 2024; 13(1):25.

PMID: 38773569 PMC: 11107038. DOI: 10.1186/s40035-024-00417-w.